Division of Pediatric Allergy and Immunology, Kocaeli University, Kocaeli, Turkey.
Division of Pediatric Allergy and Immunology, Kocaeli University, Kocaeli, Turkey.
Ann Allergy Asthma Immunol. 2019 Oct;123(4):389-393. doi: 10.1016/j.anai.2019.07.005. Epub 2019 Jul 16.
The oral provocation test (OPT) with culprit drug is the gold standard in the diagnosis of nonsteroidal anti-inflammatory drug hypersensitivity (NSAID-H). Some authors have proposed that the total number of OPTs required to diagnose NSAID-H is much lower with acetyl salicylic acid (ASA) provocations, regardless of patients' reaction history, and less time consuming.
This study aims to evaluate the total number of OPTs required to confirm NSAID-H according to the drugs (ASA or culprit NSAID) used in the initial OPT.
The study included patients with a history of NSAID-H. Data on the demographic and clinical features, coexisting chronic or allergic disease, and laboratory results were collected from medical records. The drug used for the initial OPT (ASA or culprit NSAID), results of the OPT, and the total number of OPTs were reviewed.
We included 56 children with suspected hypersensitivity reaction to NSAIDs. NSAID-H was confirmed in 21 children (37.5%). We calculated that if all OPTs were performed with culprit drugs as an initial choice, the number of OPTs required for diagnosis would be 3 or more in 85.7% of positive cases. The number of episodes was an independent risk factor for NSAID-H by multiple logistic regression analysis (odds ratio, 4.3; 95% confidence interval, 1.48-12.24; P = .007).
Performing an initial OPT with ASA regardless of patients' reaction history can result in much lower numbers of OPT to diagnose NSAID-H and can improve patient compliance.
口服激发试验(OPT)是诊断非甾体抗炎药过敏(NSAID-H)的金标准,使用 culprit 药物进行 OPT。一些作者提出,对于乙酰水杨酸(ASA)激发试验,无论患者的反应史如何,诊断 NSAID-H 所需的 OPT 总数要低得多,而且耗时更少。
本研究旨在评估根据初始 OPT 中使用的药物(ASA 或 culprit NSAID)来确定 NSAID-H 所需的 OPT 总数。
研究纳入了有 NSAID-H 病史的患者。从病历中收集了人口统计学和临床特征、共存的慢性或过敏性疾病以及实验室结果的数据。回顾了初始 OPT 中使用的药物(ASA 或 culprit NSAID)、OPT 的结果以及 OPT 的总数。
我们纳入了 56 名疑似对 NSAIDs 过敏的儿童。21 名儿童(37.5%)确诊为 NSAID-H。我们计算得出,如果所有 OPT 均使用 culprit 药物作为初始选择,则在 85.7%的阳性病例中,诊断所需的 OPT 数量将为 3 次或更多。多次逻辑回归分析显示,发作次数是 NSAID-H 的独立危险因素(优势比,4.3;95%置信区间,1.48-12.24;P =.007)。
无论患者的反应史如何,进行初始 OPT 时使用 ASA 都可以降低诊断 NSAID-H 所需的 OPT 数量,并提高患者的依从性。